RAI16 inhibitors are a class of chemical compounds that specifically target and inhibit the function of the RAI16 (Retinoic Acid-Induced 16) protein, which is involved in various regulatory roles in cellular processes. RAI16 is a gene product associated with the retinoic acid signaling pathway, where it acts as a downstream effector, helping to modulate cellular responses to retinoic acid. Retinoic acid is a metabolite of vitamin A that plays a crucial role in gene expression regulation, influencing cell differentiation, growth, and development. RAI16 is believed to contribute to transcriptional regulation by interacting with specific proteins or DNA sequences to control the expression of genes related to these processes. Inhibitors of RAI16 function by disrupting its interactions with other cellular components, blocking its ability to regulate gene transcription and interfere with cellular mechanisms dependent on retinoic acid signaling.
Inhibiting RAI16 can have significant effects on cellular function, particularly in terms of gene expression regulation, cellular differentiation, and the maintenance of homeostasis. By preventing RAI16 from engaging in its regulatory roles, these inhibitors can disrupt transcriptional programs controlled by retinoic acid signaling, leading to altered patterns of gene expression. This can affect processes such as cell proliferation, differentiation, and response to environmental signals. Researchers use RAI16 inhibitors to investigate the specific roles of RAI16 in cellular signaling and gene regulation pathways, allowing for a better understanding of how RAI16 influences cellular function at a molecular level. Furthermore, these inhibitors provide insights into the broader retinoic acid signaling network and how its various components, such as RAI16, contribute to cellular dynamics. Through the study of RAI16 inhibitors, scientists gain valuable knowledge of the molecular mechanisms underlying cellular responses to retinoic acid and how proteins like RAI16 help fine-tune gene expression to meet the needs of developing and mature cells.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
13-cis-Retinoic acid | 4759-48-2 | sc-205568 sc-205568A | 100 mg 250 mg | $75.00 $120.00 | 8 | |
This retinoid may competitively inhibit the activation of retinoic acid receptors, leading to the downregulation of RAI16 transcription as part of a negative feedback loop. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide may interfere with the transcriptional machinery necessary for RAI16 gene expression, thereby reducing its mRNA levels in the cell. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate could inhibit the promoter activity of the RAI16 gene, leading to decreased transcription and subsequent lower protein levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin may obstruct the mTOR pathway's stimulatory effect on RAI16 expression by inhibiting downstream protein synthesis. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Saturating retinoic acid receptors with exogenous Retinoic Acid may trigger a decrease in RAI16 expression by hindering receptor-mediated transcriptional activation. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate could decrease the expression of RAI16 by disrupting folate metabolism, leading to altered nucleotide synthesis and DNA methylation patterns. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 may suppress the PI3K/AKT pathway, leading to decreased transcriptional activity of genes like RAI16 that are potentially regulated by this pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
By inhibiting MEK1/2, PD 98059 could decrease RAI16 expression by preventing the activation of transcription factors targeted by the MAPK/ERK pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 may reduce RAI16 expression by inhibiting p38 MAPK, which could be vital for the expression of stress response genes including RAI16. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
This JNK inhibitor could disrupt the transcriptional activation process of the RAI16 gene, resulting in decreased protein synthesis. | ||||||